These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 16832350

  • 41. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R, Albarenque SM, Cool RH, Quax WJ, Mohr A, Zwacka RM.
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [Abstract] [Full Text] [Related]

  • 42. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.
    Goda AE, Yoshida T, Horinaka M, Yasuda T, Shiraishi T, Wakada M, Sakai T.
    Oncogene; 2008 May 29; 27(24):3435-45. PubMed ID: 18193086
    [Abstract] [Full Text] [Related]

  • 43. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death.
    Basu A, Haldar S.
    Int J Oncol; 2009 Jan 29; 34(1):281-6. PubMed ID: 19082499
    [Abstract] [Full Text] [Related]

  • 44. [Study on the effects of mitochondrial pathways on apoptosis in colon carcinoma cells induced by tumor necrosis factor related apoptosis inducing ligand].
    Hao JH, Yu M, Li Q, Shi YR, Yang Y, Hao XS.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov 29; 9(6):519-22. PubMed ID: 17143800
    [Abstract] [Full Text] [Related]

  • 45. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1328-36. PubMed ID: 19426671
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
    Tu SP, Sun YW, Cui JT, Zou B, Lin MC, Gu Q, Jiang SH, Kung HF, Korneluk RG, Wong BC.
    Cancer; 2010 Mar 01; 116(5):1252-63. PubMed ID: 20082449
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ.
    Oncol Rep; 2007 Jan 01; 17(1):175-84. PubMed ID: 17143496
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D.
    FEBS J; 2008 Apr 01; 275(8):1925-36. PubMed ID: 18341587
    [Abstract] [Full Text] [Related]

  • 54. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage.
    Jin CY, Park C, Moon SK, Kim GY, Kwon TK, Lee SJ, Kim WJ, Choi YH.
    Anticancer Drugs; 2009 Sep 01; 20(8):713-22. PubMed ID: 19617819
    [Abstract] [Full Text] [Related]

  • 55. XIAP-mediated protection of H460 lung cancer cells against cisplatin.
    Cheng YJ, Jiang HS, Hsu SL, Lin LC, Wu CL, Ghanta VK, Hsueh CM.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):75-84. PubMed ID: 19903469
    [Abstract] [Full Text] [Related]

  • 56. The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell.
    Zhou DH, Trauzold A, Röder C, Pan G, Zheng C, Kalthoff H.
    Hepatobiliary Pancreat Dis Int; 2008 Apr 10; 7(2):201-9. PubMed ID: 18397859
    [Abstract] [Full Text] [Related]

  • 57. Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.
    LaCasse EC, Cherton-Horvat GG, Hewitt KE, Jerome LJ, Morris SJ, Kandimalla ER, Yu D, Wang H, Wang W, Zhang R, Agrawal S, Gillard JW, Durkin JP.
    Clin Cancer Res; 2006 Sep 01; 12(17):5231-41. PubMed ID: 16951243
    [Abstract] [Full Text] [Related]

  • 58. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K, Hamasaki K, Ichikawa T, Arima K, Eguchi K, Ishii N.
    Oncol Rep; 2006 Aug 01; 16(2):389-92. PubMed ID: 16820920
    [Abstract] [Full Text] [Related]

  • 59. Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappaB-mediated downregulation of xIAP.
    Thayaparasingham B, Kunz A, Peters N, Kulms D.
    Oncogene; 2009 Jan 22; 28(3):345-62. PubMed ID: 18978816
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.